FDA Drug Application (016990) for INTAL by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number016990
Product Number001
FormCAPSULE;INHALATION
Dosage20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINTAL
Active IngredientCROMOLYN SODIUM

Active IngredientCount
List of drugs with Active Ingredient CROMOLYN SODIUM7


Back to FDA Applications sponsored by SANOFI AVENTIS US